CompletedNot Applicable

Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia

Japan100 participantsStarted 2005-12

Plain-language summary

In order to determine the efficacy and safety of thyroxine replacement, a randomized clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the first month of age is conducted.

Who can participate

Age range2 Weeks – 4 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Birth weight: less than 1500g * Gestation: 22 weeks 0 day ≤ * Serum free thyroxine level lower than 0.8 ng/dl * Serum thyrotropin lower than 10 μU/ml * Age of between 2 and 4 weeks after birth * Informed consent Exclusion Criteria: * any known thyroid disease in mother

What they're measuring

Psychomotor development at 1.5 years of age

Timeframe: 18 months

Trial details

NCT IDNCT00565890

SponsorTokyo Women's Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-03

View on ClinicalTrials.gov More Hypothyroxinemia trials